Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2406 (LINC02406) is a human **long intergenic non-coding RNA** (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not code for a protein and does not overlap annotated protein-coding genes[1][3]. LINC02406 is categorized as a lincRNA, a subclass of long non-coding RNAs (lncRNAs), that are implicated in gene regulatory functions such as chromatin remodeling, transcriptional regulation, and stabilization of other RNA molecules[3]. There is currently little specific functional information or direct links to disease roles, drug interactions, or clinical biomarker status for LINC02406 in the available literature or major gene databases as of September 2025[1]. Generally, lincRNAs can act as regulators of gene expression and have tissue-specific and context-dependent functions, though only a minority of the thousands of annotated lincRNAs have been functionally characterized in detail[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2406 (LINC02406).